Surgery for Infective Endocarditis in Patients on Hemodialysis

Sajjad Raza; Mohammad Adil Shiekh; Syed T. Hussain; Gosta B. Pettersson

doi:10.1007/978-3-031-65839-6_39

Surgery for Infective Endocarditis in Patients on Hemodialysis

Sajjad Raza, Mohammad Adil Shiekh, Syed T. Hussain, Gosta B. Pettersson

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Patients with end-stage renal disease on hemodialysis (HD) are at increased risk for developing infective endocarditis (HD). These patients are at increased risk compared to nonhemolysis patients when undergoing surgery for IE and have higher perioperative mortality compared to non-HD patients. The intermediate- and long-term survival are significantly worse for HD compared to non-HD patients but only slightly worse than the general HD population; however, it is significantly better than HD patients managed nonsurgically. Choice of prosthetic valve (mechanical or biologic) does not impact short- and long-term outcomes. While HD patients with IE constitute a sicker patient population with poorer operative outcomes, surgery should be considered due to significantly poor outcomes associated with nonsurgical management.

Original language	English (US)
Title of host publication	Infective Endocarditis
Subtitle of host publication	A Multidisciplinary Team Approach to a Complex Disease
Publisher	Springer Science+Business Media
Pages	579-586
Number of pages	8
ISBN (Electronic)	9783031658396
ISBN (Print)	9783031658389
DOIs	https://doi.org/10.1007/978-3-031-65839-6_39
Publication status	Published - 1 Jan 2025
Externally published	Yes

Keywords

End-stage renal disease
Heart valve replacement
Hemodialysis
Infective endocarditis
Surgery
Valvular heart disease

Access to Document

10.1007/978-3-031-65839-6_39

Cite this

@inbook{f295855e5e5d4792bce24ebf16479d7b,

title = "Surgery for Infective Endocarditis in Patients on Hemodialysis",

abstract = "Patients with end-stage renal disease on hemodialysis (HD) are at increased risk for developing infective endocarditis (HD). These patients are at increased risk compared to nonhemolysis patients when undergoing surgery for IE and have higher perioperative mortality compared to non-HD patients. The intermediate- and long-term survival are significantly worse for HD compared to non-HD patients but only slightly worse than the general HD population; however, it is significantly better than HD patients managed nonsurgically. Choice of prosthetic valve (mechanical or biologic) does not impact short- and long-term outcomes. While HD patients with IE constitute a sicker patient population with poorer operative outcomes, surgery should be considered due to significantly poor outcomes associated with nonsurgical management.",

keywords = "End-stage renal disease, Heart valve replacement, Hemodialysis, Infective endocarditis, Surgery, Valvular heart disease",

author = "Sajjad Raza and Shiekh, \{Mohammad Adil\} and Hussain, \{Syed T.\} and Pettersson, \{Gosta B.\}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.",

year = "2025",

month = jan,

day = "1",

doi = "10.1007/978-3-031-65839-6\_39",

language = "English (US)",

isbn = "9783031658389",

pages = "579--586",

booktitle = "Infective Endocarditis",

publisher = "Springer Science+Business Media",

}

TY - CHAP

T1 - Surgery for Infective Endocarditis in Patients on Hemodialysis

AU - Raza, Sajjad

AU - Shiekh, Mohammad Adil

AU - Hussain, Syed T.

AU - Pettersson, Gosta B.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.

PY - 2025/1/1

Y1 - 2025/1/1

N2 - Patients with end-stage renal disease on hemodialysis (HD) are at increased risk for developing infective endocarditis (HD). These patients are at increased risk compared to nonhemolysis patients when undergoing surgery for IE and have higher perioperative mortality compared to non-HD patients. The intermediate- and long-term survival are significantly worse for HD compared to non-HD patients but only slightly worse than the general HD population; however, it is significantly better than HD patients managed nonsurgically. Choice of prosthetic valve (mechanical or biologic) does not impact short- and long-term outcomes. While HD patients with IE constitute a sicker patient population with poorer operative outcomes, surgery should be considered due to significantly poor outcomes associated with nonsurgical management.

AB - Patients with end-stage renal disease on hemodialysis (HD) are at increased risk for developing infective endocarditis (HD). These patients are at increased risk compared to nonhemolysis patients when undergoing surgery for IE and have higher perioperative mortality compared to non-HD patients. The intermediate- and long-term survival are significantly worse for HD compared to non-HD patients but only slightly worse than the general HD population; however, it is significantly better than HD patients managed nonsurgically. Choice of prosthetic valve (mechanical or biologic) does not impact short- and long-term outcomes. While HD patients with IE constitute a sicker patient population with poorer operative outcomes, surgery should be considered due to significantly poor outcomes associated with nonsurgical management.

KW - End-stage renal disease

KW - Heart valve replacement

KW - Hemodialysis

KW - Infective endocarditis

KW - Surgery

KW - Valvular heart disease

UR - https://www.scopus.com/pages/publications/105008167551

U2 - 10.1007/978-3-031-65839-6_39

DO - 10.1007/978-3-031-65839-6_39

M3 - Chapter

AN - SCOPUS:105008167551

SN - 9783031658389

SP - 579

EP - 586

BT - Infective Endocarditis

PB - Springer Science+Business Media

ER -

Surgery for Infective Endocarditis in Patients on Hemodialysis

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this